Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “AstraZeneca”
- Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) DiseaseRecruiting
Sponsor: AstraZeneca
Respiratory Syncytial Virus (RSV)
India
- Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Osimertinib (TAGRISSO) (ROSY-T)Active Not Recruiting
Sponsor: AstraZeneca
Cancer
China, France, Japan, Malaysia, Poland +3 more
- A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal CancerNot Yet Recruiting
Sponsor: Memorial Sloan Kettering Cancer Center
Colorectal Cancer · Adenocarcinoma of the Colon · Adenocarcinoma of the Rectum
United States
Sponsor: AstraZeneca
Lysosomal Acid Lipase Deficiency
Russia
Sponsor: AstraZeneca
Ovarian Cancer · Prostate Cancer
China
Sponsor: AstraZeneca
Neurofibroma
Russia
Sponsor: AstraZeneca
Severe Eosinophilic Asthma
Italy
Sponsor: AstraZeneca
Chronic Heart Failure
United States, Bulgaria, Czechia, Denmark, Hungary +5 more
- Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin LymphomaActive Not Recruiting
Sponsor: Acerta Pharma BV
Non Hodgkin Lymphoma
United States, Canada, Italy
- Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CMNot Yet Recruiting
Sponsor: AstraZeneca
Transthyretin Amyloid Cardiomyopathy
United States, Germany, Portugal, Spain
- Prospective Observational Multicenter Study of Patients With AH and CKD Markers in Kazakhstan (PROGRESS-CKD)Active Not Recruiting
Sponsor: AstraZeneca
Rate of CKD Diagnosis in Patients With AH and CKD Markers · Demographic and Clinical Characteristics for Those Patients · Routine Therapy Before and After the Diagnosis of CKD
Kazakhstan
Sponsor: AstraZeneca
Unresectable Breast Cancer · Metastatic Breast Cancer · HER2-low Expressing Breast Cancer · HER2-positive Breast Cancer
Canada
- Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder CancerActive Not Recruiting
Sponsor: AstraZeneca
Non-muscle-invasive Bladder Cancer
Australia, Austria, Belgium, Canada, France +7 more
Sponsor: AstraZeneca
Type 2 Diabetes
United States, Brazil, Hungary, India, Malaysia +2 more
Sponsor: AstraZeneca
Breast Cancer
France
- Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer PatientsActive Not Recruiting
Sponsor: AstraZeneca
Advanced Ovarian Cancer
United States, Austria, Belgium, Brazil, Bulgaria +15 more
- Study to Characterise Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Anifrolumab Administered Subcutaneously (SC) or Intravenously (IV)Not Yet Recruiting
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
Sponsor: AstraZeneca
Breast Cancer
South Korea
- Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast CancerActive Not Recruiting
Sponsor: AstraZeneca
Breast Cancer
United States, Australia, Austria, Belgium, Germany +4 more
- A Phase IIIb Study to Investigate the Effect of Baxdrostat in Chinese Participants With Uncontrolled Hypertension.Not Yet Recruiting
Sponsor: AstraZeneca
Uncontrolled Hypertension
- Fasenra: An Asthma StudyNot Yet Recruiting
Sponsor: Endeavor Health
Eosinophilic Asthma · Severe Asthma · Severe Eosinophilic Asthma · Asthma
United States
- A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)Active Not Recruiting
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
United States, China, Germany, Israel, Italy +1 more
- A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid TumoursActive Not Recruiting
Sponsor: AstraZeneca
Advanced Solid Tumor · Metastatic Colorectal Carcinoma · Head and Neck Squamous Cell Carcinoma · Non-small Cell Lung Cancer
United States, Canada
- Durvalumab and Tremelimumab for Pediatric MalignanciesActive Not Recruiting
Sponsor: AstraZeneca
Pediatric Cancer · Solid Tumor Pediatric · Hematological Malignancies
United States, France, Germany, Italy, Netherlands +2 more
Sponsor: Stanford University
Non-small Cell Lung Cancer · Non-small Cell Lung Cancer Stage I · Non-small Cell Lung Cancer Stage II · Non-small Cell Lung Cancer Stage III
United States